Target intelligence / Profile preview

Acyl-coenzyme A thioesterase 8 (ACOT8)

Target
ACOT8
Molecular classification
Enzyme, Thioesterase, Peroxisomal protein
01

Overview

Acyl-coenzyme A thioesterase 8 (ACOT8) is a peroxisomal enzyme that catalyzes the hydrolysis of acyl-CoA esters to free fatty acids and coenzyme A, thus regulating intracellular acyl-CoA and free fatty acid levels. It plays a significant role in fatty acid metabolism, including the β-oxidation pathway, and participates in the metabolism of bile acid CoA esters and dicarboxylic acids. ACOT8 displays broad substrate specificity for medium- to long-chain acyl-CoAs but is inactive on substrates with very long aliphatic chains. The enzyme is involved in metabolic regulation of peroxisome proliferation and interacts with the HIV-1 Nef protein, where it may mediate Nef-induced down-regulation of CD4 in T-cells, suggesting a possible link to HIV infection biology. Despite its central metabolic roles, no drugs directly target ACOT8 currently, and its function in human disease outside of rare associations remains under investigation.

Other names
ACOT8Acyl-CoA thioesterase 8ACTEIIIPTE1PTE2HACTE-IIIhACTEIIIhTENAP1Choloyl-coenzyme A thioesteraseHIV-Nef-associated acyl-CoA thioesterasePeroxisomal acyl-CoA thioesterase 2Peroxisomal acyl-coenzyme A thioester hydrolase 1Peroxisomal long-chain acyl-CoA thioesterase 1Thioesterase IIThioesterase IIICholoyl-CoA hydrolaseNef (lentivirus myristoylated factor) associated protein 1
02

Mechanism of action

Not applicable (no drugs established to act directly on ACOT8). Any future mechanism would likely involve inhibition or modulation of acyl-CoA hydrolysis.

03

Biological functions

Fatty acid metabolismPeroxisomal β-oxidation of fatty acidsRegulation of intracellular acyl-CoA and free fatty acid levelsHydrolysis of acyl-CoAs to free fatty acids and Coenzyme AInteraction with HIV-1 Nef proteinRegulation of cellular protein lipidationBile acid metabolism
04

Disease associations

Infection (notably HIV, via interaction with HIV-1 Nef)Flinders Island spotted fever (association)Alpha-methylacyl-CoA racemase deficiency (association)Other / lipid metabolism disorders (putative)
05

Safety considerations

None established; as of present, no drugs targeting ACOT8 are in clinical or preclinical use, so direct safety/therapeutic risk data are lacking.
06

Interacting drugs

None established for clinical use or specifically targeting ACOT8 as of current knowledge; no approved or experimental drugs reported directly.
07

Biomarkers

None routinely established; no clinical biomarkers in use for ACOT8 as a therapeutic/disease monitoring marker.

Beyond the preview

Go deeper on Acyl-coenzyme A thioesterase 8 (ACOT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-coenzyme A thioesterase 8 (ACOT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call